Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pustulosis Palmaris et Plantaris”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Post-approval studies (Phase 4)Ended earlyNCT05710185
What this trial is testing

Deucravacitinib for the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Brigham and Women's Hospital 3
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Large-scale testing (Phase 3)Study completedNCT04061252
What this trial is testing

KHK4827 in Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Kyowa Kirin Co., Ltd. 126
Not applicableLooking for participantsNCT07270003
What this trial is testing

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Xijing Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00301002
What this trial is testing

Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis

Who this might be right for
PsoriasisPalmoplantaris PustulosisPustular Psoriasis of Palms and Soles+2 more
The Guenther Dermatology Research Centre 15
Post-approval studies (Phase 4)Looking for participantsNCT07503652
What this trial is testing

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University 10
Testing effectiveness (Phase 2)Study completedNCT03135548
What this trial is testing

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Who this might be right for
Psoriasis
Boehringer Ingelheim 59
Testing effectiveness (Phase 2)Ended earlyNCT01197989
What this trial is testing

Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis

Who this might be right for
Pustulosis of Palms and Soles
Lenzi Egisto S.P.A. 17
Not applicableStudy completedNCT01780857
What this trial is testing

Immune Signature of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Baylor Research Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT05194839
What this trial is testing

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Aristea Therapeutics, Inc. 79
Testing effectiveness (Phase 2)Study completedNCT04057937
What this trial is testing

Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Amgen 90
Early research (Phase 1)Study completedNCT03972280
What this trial is testing

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

Who this might be right for
Hidradenitis SuppurativaPalmoplantar Pustulosis
CSL Behring 39
Testing effectiveness (Phase 2)Study completedNCT04572997
What this trial is testing

Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)

Who this might be right for
Palmoplantar Pustulosis
Kristian Reich 21
Large-scale testing (Phase 3)Looking for participantsNCT07219420
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
UCB Biopharma SRL 300
Testing effectiveness (Phase 2)Ended earlyNCT04493424
What this trial is testing

Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab

Who this might be right for
Palmoplantar Pustulosis
Boehringer Ingelheim 108
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Testing effectiveness (Phase 2)Study completedNCT03988335
What this trial is testing

Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Aristea Therapeutics, Inc. 35
Load More Results